Constantinos Panagos - Sep 19, 2023 Form 4 Insider Report for IQVIA HOLDINGS INC. (IQV)

Role
President, Research & Development Solutions
Signature
/s/ Matthew Gilmartin, Attorney-in-Fact for Costa Panagos
Stock symbol
IQV
Transactions as of
Sep 19, 2023
Transactions value $
-$5,700,822
Form type
4
Date filed
9/21/2023, 06:01 PM
Previous filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IQV Common Stock Sale -$4.15M -19.9K -58.27% $208.69 14.3K Sep 19, 2023 Direct F1
transaction IQV Common Stock Options Exercise $272K +2.85K +20.02% $95.23 17.1K Sep 19, 2023 Direct
transaction IQV Common Stock Options Exercise $1.01M +7.68K +44.91% $131.82 24.8K Sep 19, 2023 Direct
transaction IQV Common Stock Options Exercise $1.81M +11.2K +45.2% $161.70 36K Sep 19, 2023 Direct
transaction IQV Common Stock Options Exercise $818K +4.45K +12.37% $183.82 40.4K Sep 19, 2023 Direct
transaction IQV Common Stock Sale -$1.55M -7.42K -18.35% $208.63 33K Sep 19, 2023 Direct F2
transaction IQV Common Stock Disposed to Issuer -$3.91M -18.8K -56.84% $208.56 14.3K Sep 19, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IQV Stock Appreciation Right Options Exercise $0 -2.85K -100% $0.00* 0 Sep 19, 2023 Common Stock 2.85K $95.23 Direct
transaction IQV Stock Appreciation Right Options Exercise $0 -7.68K -100% $0.00* 0 Sep 19, 2023 Common Stock 7.68K $131.82 Direct
transaction IQV Stock Appreciation Right Options Exercise $0 -11.2K -100% $0.00* 0 Sep 19, 2023 Common Stock 11.2K $161.70 Direct
transaction IQV Stock Appreciation Right Options Exercise $0 -4.45K -66.67% $0.00 2.23K Sep 19, 2023 Common Stock 4.45K $183.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

President, Research & Development Solutions